CTOs on the Move

Meditrina, Inc

www.meditrina-inc.com

 
Meditrina, a startup company located in Cupertino, CA, was founded in 2016, and developed the Aveta™ System, a single-use Hysteroscope and Resecting Device, with an all-inclusive HD Visualization and Fluid Management system. A new office Hysteroscopy system which can also be used in the clinic or hospital operating room (OR), for diagnostic or therapeutic Hysteroscopy procedures. Procedures include: Diagnostic Hysteroscopy, biopsy, and soft tissue removal such as, fibroids, polyps, and/or retained products of conception (RPOC).
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Meditrina, Inc raised $13M on 10/02/2019

Similar Companies

Sechrist Industries Inc

Sechrist Industries Inc is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Neurolens

Modern lifestyles and persistent near vision utilization cause a majority of patients to experience the reduced visual acuity and painful symptoms of eye misalignment – headaches, eye strain, neck and shoulder pain, motion sickness and dry eye sensation. Neurolens addresses common binocular vision issues using a three-step process. Step one is efficiently identifying patient symptomology using a basic online symptom screener that every patient can complete in minutes. This information goes directly to the Neurolens Measurement Device, Gen 2—or NMD2—ready for step two, which is accurately and objectively measuring the patient`s level of misalignment. The NMD2 is an objective, accurate and repeatable way to measure eye misalignment as small as 0.01 Prism Diopters. Most importantly, step three is correcting eye misalignment with a proven lens solution. Neurolenses address binocular vision issues by providing a contoured prism lens design that gradually delivers more prism in the lens corridor from distance to near. Neurolenses are proven to have a profound impact on a patient`s visual clarity and comfort. In fact, 93% of patients responded positively to wearing Neurolenses. Over 81% of patients suffering from chronic daily headaches reported their symptoms were substantially reduced or basically gone after wearing Neurolenses for 90 days. Neurolens—recognized in 2022 as one of the 30 fastest growing private companies in the healthcare industry by Inc. Magazine—is confident that appropriately addressing growing binocular vision issues will become a standard of care in this industry, unlocking dramatic patient outcomes and practice growth.

Diamedix

Diamedix Corp. is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ActiveMD

ActiveMD is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Intraop Medical Corporation

Intraop Medical Corporation is a Sunnyvale, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.